Dashenlin Pharmaceutical Group Co., Ltd. Class ASSE: 603233

"DaShenLin Pharmaceutical Group Co., Ltd."Notice on Convening the 2nd Extraordinary General Meeting in 2026

· Issued by Dashenlin Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Notice on Convening the 2nd Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Dashenlin Pharmaceutical Group Co., Ltd. Class A

All Dashenlin Pharmaceutical Group Co., Ltd. Class A news releases